GLI1 and neoplasm: GDC-0449 inhibited gene expression of PTCH1 and GLI1. Moreover, a reduction in proliferation was seen after GDC-0449 treatment by means of decreased Ki67 expression level; however, no change in tumor volume was observed [73].